|
Baum C, Reichenspurner H, Deuse T. Bortezomib rescue therapy in a patient with recurrent antibody-mediated rejection after lung transplantation. Heart Lung Transplant 2013 Sep 13. pii: S1053-2498 (13) 01413-7. |
|
|
Cypel M, Keshavjee S. Strategies for safe donor expansion: donor management, donations after cardiac death, ex-vivo lung perfusion. Curr Opin Organ Transplant 2013 Aug 29. [Epub ahead of print] |
|
|
Eberlein M, Diehl E, Bolukbas S, Merlo CA, Reed RM. An oversized allograft is associated with improved survival after lung transplantation for idiopathic pulmonary arterial hypertension. J Heart Lung Transplant 2013 Jul. |
|
|
Snell GI, Holmes M, Levvey BJ, Shipp A, Robertson C, Westall GP, Cohney S. Lessons and Insights From ABO-Incompatible Lung Transplantation. Am J Transplant 2013 May; 13 (5): 1350-3. |
|
|
Bittle GJ, Sanchez PG, Kon ZN, Claire Watkins A, Rajagopal K, Pierson RN 3rd, Gammie JS, Griffith BP. The use of lung donors older than 55 years: A review of the United Network of Organ Sharing database. J Heart Lung Transplant 2013 May 9. |
|
|
Roman MA, Nair S, Tsui S, Dunning J, Parmar JS. Ex Vivo Lung Perfusion: A Comprehensive Review of the Development and Exploration of Future Trends. Transplantation. 2013 May 20. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|